CORONA, Calif., Feb. 5 -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the company expects to initiate shipments of alendronate sodium in ...

Please provide your email address to receive an email when new articles are posted on . Women who have ever used alendronate sodium may be at an increased risk of incident atrial fibrillation, ...

This drug had not previously been considered by the PBAC for this indication. Osteoporosis must be confirmed by the finding of low bone mass of at least 2 standard deviations below the gender specific ...

BANGALORE, Sept 12 (Reuters) - India's Sun Pharmaceutical Industries said it has received approval from the U.S. Food and Drug Administration to market alendronate sodium tablets, the generic version ...

Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially ...

Sun Pharma announced a recall of Alendronate Sodium Tablets 70mg, the generic version of Fosamax. Sun Pharma announced a recall of Alendronate Sodium Tablets 70mg, the generic version of Merck‘s ...

BINOSTO (alendronate sodium) 70mg effervescent tablet for oral solution by Mission Pharmacal Mission Pharmacal Company announced that Binosto (alendronate sodium) effervescent tablet for buffered oral ...

April 14, 2005 -- The U.S. Food and Drug Administration (FDA) has approved mometasone furoate inhalation powder for the maintenance treatment of asthma as prophylactic therapy in patients aged 12 ...

DEAR DR. GOTT: I’m an 83-year-old female. I take a weekly 70-milligram alendronate sodium tablet for osteoporosis, 50 milligrams of blood-pressure medicine and 20 milligrams of a cholesterol ...

Please provide your email address to receive an email when new articles are posted on . “Glucocorticoids are the mainstay of treatment of autoimmune inflammatory diseases, but it is also the leading ...

WHITEHOUSE STATION, N.J., November 23, 2009 - Merck said today that U.S. District Court Judge John F. Keenan granted summary judgment in Merck's favor in Flemings v. Merck. Flemings is the second of ...